[236 Pages Report] The global meningococcal vaccines market is expected to grow at an 8.6% CAGR during the forecast period, reaching US$ 3.4 billion in 2022. According to Future Market Insights (FMI), the conjugate vaccines segment will have a 62.6% revenue share in 2021. Partnerships between the private sector and public institutions have been the chief agenda …
Category Archives: Healthcare Trends
Home Rehabilitation Services Market slated to increase at a CAGR of 4.8%, to reach US$ 140.5 Billion by 2032
[250 Pages Report] According to Future Market Insight’s latest analysis, the global home rehabilitation services market was valued at over US$ 84.1 Bn in 2021 and is expected to exhibit a CAGR of close to 4.8% over the forecast period (2022-2032). The home rehabilitation services market is witnessing a high demand owing to the rising prevalence of chronic disease, surge in the population with …
Drastic Rise in Dermatological Cases has Elevated the Demand for Light Therapy. FMI Registers a CAGR of 5.7% through 2033
[306 Pages Report] According to FMI reports, the global light therapy market can soar at a rate CAGR of 5.7% from 2023-2033. The net worth of the market share of the light therapy industry is predicted to grow from US$ 1.0 Billion in 2023 to over US$ 1.8 Billion by 2033. The global light therapy market is …
Medication Management System Market is anticipated to garner US$ 7.1 Billion by 2032
In 2022, the global medication management system market is expected to be worth US$ 2.5 billion. The global medication management system market is expected to grow at a CAGR of 11% between 2022 and 2032, totalling US$ 7.1 billion. The market’s expansion can be attributed to hospitals’ increasing investment in improving workflow and the rapid …
Nucleic Acid Testing Market is predicted to grow at CAGR of 6.8% through 2033
The global nucleic acid testing market is expected to reach $3.7 billion by 2023. The market is expected to reach US$ 7.2 billion by 2033, growing at a healthy 6.8% CAGR. Increased government and private sector investment in the development of novel biotechnological diagnostic techniques, as well as high demand for technologically advanced diagnostic measures, …
Continue reading “Nucleic Acid Testing Market is predicted to grow at CAGR of 6.8% through 2033”
Neurological Biomarkers Market is predicted to grow at a CAGR of 4.6% through 2033
The global neurological biomarkers market is projected to have a high-paced CAGR of 4.6% during the forecast period. The current valuation of the neurological biomarkers market is US$ 8 Billion in 2023. The value of the neurological biomarkers market is anticipated to reach a high of US$ 12.5 Billion by the year 2033. The key features pushing …
Dental Hygiene Devices Market is expected to register 4.8% CAGR through 2028
The Dental Hygiene Devices Market is expected to be worth USD 4.4 billion in 2022 and USD 5.9 billion by 2028, growing at a CAGR of 4.8% during the forecast period (2022 to 2028). Basic dental hygiene devices include toothpastes and toothbrushes. Dental hygiene devices are designed to aid in the maintenance of oral hygiene, …
Continue reading “Dental Hygiene Devices Market is expected to register 4.8% CAGR through 2028”
Bioimpedance Devices Market is expected to reach US$ 715.1 million by 2028
The global Bioimpedance Devices Market is expected to exceed US$ 492.1 Million in 2022. The market is expected to reach US$ 715.1 Million by 2028, growing at a healthy 6.4% CAGR. Increasing CKD disease cases are expected to fuel the growth of the Bioimpedance Devices Market over the forecast period. Chronic kidney disease (CKD) is …
Continue reading “Bioimpedance Devices Market is expected to reach US$ 715.1 million by 2028”
Onychomycosis Treatment Market is expected to secure US$ 10 Billion by 2032
In 2022, the global onychomycosis treatment market is expected to be worth US$ 4.44 billion. From 2022 to 2032, the onychomycosis treatment market is expected to grow at an 8.46% CAGR and reach a value of US$ 10 billion. The market’s expansion can be attributed to the rising prevalence of diabetes, which increases the risk …
Continue reading “Onychomycosis Treatment Market is expected to secure US$ 10 Billion by 2032”
Paediatric Spasticity Treatment Market is likely to register a CAGR of 10% from 2022-2032 | FMI
[324 Pages Report] During the forecast period, the paediatric spasticity treatment market is expected to grow at a CAGR of 10%. Rising demand for combination products such as benzodiazepines, imidazole, and gamma-aminobutyric acid analogues is driving the global paediatric spasticity treatment market. Furthermore, demand for paediatric spasticity treatment is increasing as a result of increased awareness and …